Relief Therapeutics Holding AG (RLFTF)

[Whalatane]

Insight .. HGEN may have data before RLFTF ..following up on Nels posts and Dr Javitts comments apparently around 9/9 that they RLFTF / NeuroRx are roughly a month away from unblinded data.

Comparing the data I've looked at for Lenzilumab ( HGEN ) vs RLF-100 ...so far ...HGEN study of 39 patients and RLFTF's open label data ....RLF-100 looks to be the better drug


BUT double blinded placebo controlled data from both will ultimately answer that question .

Re RVVTF. as front runner ? I think you meant RLFTF ...RVVTF doesn't have the funding ( as least as far as I can find ) to mount a P 3 trial . HGEN is well funded and RLFTF certainly now has enough $ to finish the IV trial and at least start the Inhaler trial

Kiwi